Rhonda Schaffler is Editor-At-Large at TheStreet and Anchor of TheStreet TV. Schaffler has worked for over two decades as a broadcast financial journalist for global organizations including Reuters, CNN, Dow Jones and Bloomberg. She was a winner of the 2011 Society of American Business Editors and Writers Award for Excellence in Financial Journalism, Multimedia. Rhonda graduated with honors from Penn State University with a B.A. in Journalism and Political Science.
Recent Articles By The Author
Memorial Day Entertaining on a Budget: Here's How to Feed a Crowd for $50
For many Americans, Memorial Day weekend means rest, relaxation, and for some of us, entertaining.
Unprepared for Surprise Bills, Consumers Land in Long-Term Debt
One unexpected bill can set families back for an entire year, according to a new study.
3-D Printed Products Span the Gamut from Useful to Just Plain Weird
There's are surprising number of things you can make with 3D printers.
After Snap Goes Public, Could Uber and Airbnb Be Next?
The Snap IPO could be just the beginning of a wave of new technology initial public offerings.
Trump Tax Talk Pushes the Market to Record Highs: Real Money's Stephen Guilfoyle
Real Money's Stephen Guilfoyle says the market could continue to rise next week.
This Year's 5 Top Luxury Travel Trends May Surprise You
Here's a look at the top luxury travel trends for 2017.
Why Jim Cramer Prefers Pepsi to Coca-Cola
For now, Jim Cramer prefers PepsiCo as an investment over Coca-Cola.
There's No Reason to Buy Twitter Stock on Its Big Drop, Says Jim Cramer
Jim Cramer explains why Twitter is in a very tough spot.
GE Stock Has Been Disappointing, the CEO Needs to Turn Things Around, Says Jim Cramer
Jim Cramer says GE needs to turn things around before it becomes a "must not own" stock.
Acorda Therapeutics Stock Surges on Clinical Trial Results
Acorda Therapeutics announced positive results in a clinical trial for its drug CVT-301.